PRLD 8-K 2026-09-10

Prelude Therapeutics Inc (PRLD) 8-K dated 2026-09-10 — accession 0001193125-26-387232. This URL is the filing, not the PRLD hub.

Prelude Therapeutics Inc (PRLD) is a biotechnology company listed on NASDAQ.

Prelude Therapeutics Inc filed a 8-K on 2026-09-10. Accession 0001193125-26-387232.

Cached items: 7.01, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported PRLD revenue for 2025-12-31 was $12.1M. Net income was -$99.5M. Revenue was up 73.4% from 2024-12-31 to 2025-12-31. PRLD currently screens at market cap $346.5M.

Not investment advice. The PRLD SEC hub lists recent forms. The stock page is the research view.